Skip to main content
Fig. 2 | Journal of Translational Medicine

Fig. 2

From: Increased Th17 cells and IL-17A exist in patients with B cell acute lymphoblastic leukemia and promote proliferation and resistance to daunorubicin through activation of Akt signaling

Fig. 2

The levels of Th17-associated cytokines were increased in PB and BM samples from patients with B-ALL. The PB and BM samples were aspirated from B-ALL patients and healthy donors (HD) and determined for the levels of IL-17 (a), IL-21 (b), IL-23 (c), IL-1β (d), and IL-6 (e) using ELISA. Statistical data were expressed as mean ± SEM

Back to article page